High-Throughput Screening Market Size, Share, Key Players and Future Scope

North America has been the largest market for high-throughput screening, owing to its increased awareness, increasing government funding, established healthcare industry, and easy accessibility to advanced technologies due to the awareness in the region. North America has been the largest market for high-throughput screening, owing to its increased awareness, increasing government funding, established healthcare industry, and easy accessibility to advanced technologies due to the awareness in the region.

psmarketresearch12
from psmarketresearch12 More from this publisher
11.12.2019 Views

BiotechnologyHigh-Throughput Screening Market Size,Share, Segment Analysis and ForecastReport 2024© P&S Intelligence. All rights reserved1

Biotechnology

High-Throughput Screening Market Size,

Share, Segment Analysis and Forecast

Report 2024

© P&S Intelligence. All rights reserved

1


The global high-throughput screening market is witnessing considerable

growth due to increasing geriatric population, increasing healthcare

expenditure, increasing research and development activities, launch of

technologically advanced products that are miniaturized and automated and

growing popularity of high-throughput screening for drug discovery.

Moreover, high adoption of high-throughput screening models in

pharmaceutical and biotechnology companies across the globe is supporting

the growth of the market. Based on technology, 2D cell culture segment is

expected to grow at the fastest rate during the forecast period owing to its

low cost and ease of use.

Request for sample copy of this report at:

https://www.psmarketresearch.com/market-analysis/high-throughputscreening-market/report-sample

The rapid growth in emerging economies and growing research and

development activities on stem cells and toxicology is expected to create

opportunities for the manufacturers of high-throughput screening products.

However, high cost of high-throughput screening, lack of trained

professionals and complexity in assay development are the key factors

hampering the growth of the global market.

Geographically, North America has been the largest market for highthroughput

screening, owing to its increased awareness, increasing

government funding, established healthcare industry, and easy accessibility

to advanced technologies due to the awareness in the region. The U.S.

contributed largest revenue to the North American as well as global highthroughput

screening market. The increased research and development

activities and increasing prevalence of chronic diseases arising the need for

novel treatments is the key growth driving factor for the U.S. highthroughput

screening market.

© P&S Intelligence. All rights reserved

2


Europe has been the second largest market for high-throughput screening,

where the market is driven by the presence of a large pool of patients,

increasing healthcare expenditure and rapidly developing healthcare

infrastructure. In 2015, Germany led the European high-throughput

screening market and it is also expected to grow at the fastest rate in Europe,

during forecast period. Globally, the high-throughput screening market is

expected to witness the fastest growth in Asia-Pacific during the forecast

period. The highest growth in the region is attributed to the increasing

research and development activities, increasing per capita income leading to

improving standard of living, increasing healthcare spending, growing

demand for better quality medical care, and awareness about highthroughput

screening in the region.

The key players operating in the global market are Agilent Technologies, Inc,

Danaher Corporation, Thermo Fisher Scientific Inc., Merck Millipore, Bio-Rad

Laboratories, Inc., Hamilton Company and Aurora Biomed, Inc.

Read More: https://www.psmarketresearch.com/market-analysis/highthroughput-screening-market

© P&S Intelligence. All rights reserved

3


Disclaimer:

P&S Intelligence always keeps its customers’ interests at the core while carrying out research

activities. P&S Intelligence ensures the reliability and accuracy of information and data provided in

its market research publications. However, the information in publications is subject to fluctuations,

as it is based on primary interviews of officials from various companies or organizations. P&S

Intelligence is not responsible for any incorrect data provided by the key industry players of the

concerned domain. The information or analysis in P&S Intelligence publications represents opinions

based on research and should not be interpreted as statements of fact. Information in this report

was believed to be correct at the time of publication, but cannot be guaranteed. P&S Intelligence

does not endorse any product, service, or vendor depicted in its research publications.

All intellectual properties, including trademarks and copyrights, belong to their respective owners

and may be protected by copyright. Under no circumstance can these be reproduced in any form

without prior written agreement of their owners.

An order for market research report is intended for internal use of the company only and not for

disclosure to third parties or any other publication in general. No service, report, or part thereof

provided by P&S Intelligence can be reproduced, republished, resold, revealed, distributed,

circulated, or sublicensed in any medium or form now realized or hereafter become realized,

including but not limited to, all forms of optical-based media, magnetic, electronic, or digital,

without a written permission from Prescient & Strategic Intelligence Pvt. Ltd.

Kindly write to: enquiry@psmarketresearch.com

B-13, Sector – 2, Noida, U.P. – 201301, INDIA

Contact No: +91 120 4541 337

US/Canada Toll-Free: 1-888-778-7886

© P&S Intelligence. All rights reserved

4

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!